Skip to main content

Table 1 Relationship between clinicopathological factors and PNI

From: Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer

Variables

 

n (%)

PNI, mean ± SD

P value

Age (year)

65

102 (48)

53.1 ± 4.1

<0.001

 

>65

110 (52)

50.8 ± 5.2

 

Histology

Ductal

191 (90)

51.9 ± 4.7

0.291

 

Lobular

9 (4)

49.2 ± 5.0

 
 

Special

12 (6)

53.4 ± 6.2

 

Tumor size (cm)

2

145 (68)

52.3 ± 4.8

0.166

 

>2, 5

61 (29)

50.9 ± 5.0

 
 

>5

6 (3)

51.7 ± 4.0

 

Nodal metastasis

0

168 (79)

52.0 ± 5.0

0.240

 

1–3

28 (13)

52.0 ± 4.4

 
 

>3

16 (8)

50.1 ± 3.7

 

Stage

0/I

135 (64)

52.3 ± 4.8

0.124

 

II

58 (27)

51.5 ± 4.9

 
 

III

19 (9)

50.5 ± 4.5

 

Estrogen receptor status

Positive

168 (79)

51.8 ± 5.0

0.682

 

Negative

44 (21)

52.3 ± 4.4

 

Progesterone receptor status

Positive

145 (68)

51.8 ± 5.0

0.879

 

Negative

67 (32)

52.1 ± 4.6

 

HER2 status

Positive

39 (18)

51.0 ± 4.8

0.152

 

Negative

173 (82)

52.1 ± 4.8

 

CEA (ng/ml)

<5

164 (77)

51.9 ± 4.6

0.953

 

≥5

48 (23)

51.9 ± 5.5

 

CA 15-3 (U/ml)

<23

199 (94)

52.0 ± 4.8

0.327

 

≥23

13 (6)

50.4 ± 5.1

 
  1. PNI prognostic nutritional index, ER estrogen receptor, PR progesterone receptor, HER-2 human epidermal growth factor receptor 2